Dow Futures Rise as Novavax Reports Its Progress in COVID-19 Vaccine Development

Coinspeaker
Dow Futures Rise as Novavax Reports Its Progress in COVID-19 Vaccine Development

American biotech company Novavax said it had started the first human study of its experimental coronavirus vaccine, with initial results on safety and immune responses expected in July. The U.S. futures positively reacted to the news.

Dow Futures Rise as Novavax Reports Its Progress in COVID-19 Vaccine Development

Coinspeaker

46 total views, 1 views today

Author: toutiao